MPM BioVentures 2014, L.P. 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 4:15 pm Sale | 2025-01-31 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 1,941,242 4.600% | -208,173 (-9.69%) | Filing |
| 2025-01-15 6:43 pm Sale | 2025-01-13 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 2,149,415 5.100% | -509,117 (-19.15%) | Filing |
| 2025-01-06 4:49 pm Sale | 2025-01-02 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 2,658,532 6.300% | -642,324 (-19.46%) | Filing |
| 2024-12-26 4:34 pm Purchase | 2024-12-20 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 3,300,856 7.800% | 3,300,856 (New Position) | Filing |